Flex Pharma Shares Plunge After Biotech Ends 2 Clinical Trials, Announces 60% Workforce Cut
Flex Pharma Inc (NASDAQ: FLKS) shares are slumping on above-average volume Wednesday following a release from the company announcing the scrapping of two clinical trials and the explo read more.....»»
Vaccinex Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
On-track to report topline data from CLASSICAL-Lung and SIGNAL clinical trials this year Announces expansion of pepinemab development program into Alzheimer's disease Completes private placement of c.....»»
Inovio shares rally after biotech says human trials of coronavirus vaccine will start in April
Shares of Inovio Pharmaceuticals Inc. rallied more than 16% Tuesday, after the company said it’s accelerating the timeline for development of a vaccine to treat the coronavirus COVID-19 and expects to start human trials in the U.S. next month......»»
Gilead announces more trials for drug aimed at COVID-19, stock up 4%
Shares of Gilead Sciences Inc. rose nearly 4% in th.....»»
Nanocap Biotech Stock Rips 180% Higher On Coronavirus Drug Licensing
Cocrystal Pharma Inc (NASDAQ: COCP) shares are skyrocketing Monday following a licensing agreement the company reached with the Kansas State University Research Foundation. read more.....»»
Foamix announces results from two pivotal Phase 3 clinical trials for FMX103
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Moleculin Biotech announces data from its CTCL clinical trial of WP1220
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN) Aptose Biosciences .....»»
Vertex Pharma stock rises on earnings, outlook beat
Vertex Pharmaceuticals Inc. shares rose in the extended session Thursday after the biotech drug maker's results and forecast topped Wall Street estimates. Vertex shares rose 2.9% after .....»»
Pharma company gets $2.7M grant to continue "positive" Alzheimer"s treatment trials
Neurotrope announced the results of its latest confirmatory clinical trial......»»
The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings
Biotech news flow remained light last week, although there were some notable developments such as FDA panel reviews of opioid pain drugs, a few clinical data readouts, presentations and updates at the JPMorgan Healthcare conference. Here are the key c.....»»
What"s Driving The aTyr Pharma Rally?
Shares of the thinly traded nano-cap biotech aTyr Pharma Inc (NASDAQ: LIFE) were advancing strongly Monday on above-average volume. 0 read more.....»»
UPDATE: Spring Bank Pharma shares slide 45% premarket after it halts trial of treatment for hepatitis B virus
Spring Bank Pharmaceutical Inc.'s shares slid 45% in premarket trade Thursday, after the clinical-stage biopharma company said it has stopped dosing patients in a trial of a treatment for.....»»
Spring Bank Pharma shares slide 17% premarket after it halts trial of treatment for hepatitis B virus
Spring Bank Pharmaceutical Inc.'s shares slid 17% in premarket trade Thursday, after the clinical-stage biopharma company said it has stopped dosing patients in a trial of a treatment for.....»»
Allergan"s migraine drug approved by FDA
Shares of Allergan gained 0.5% after the Food and Drug Administration approved Ubrelvy, its migraine treatment. In two late-stage clinical trials, more patients who were taking the experimental therapy reported the pain ending within t.....»»
Cincinnati Children’s strikes deal with pharma firms
Cincinnati Children’s Hospital has entered into an agreement to advance clinical development of a medicine that involves several pharmaceutical firms. Fortress Biotech Inc. disclosed today that Baergic Bio Inc., a newly formed Fortress partner .....»»
Mid-Day Market Update: Steelcase Surges On Upbeat Q3 Results; Aduro BioTech Shares Plunge
Midway through trading Wednesday, the Dow traded up 0.04% to 28277.07 while the NAS.....»»
High Flying Biotech Axsome Skyrockets On Positive Late-Stage Results For Depression Drug
Shares of Axsome Therapeutics Inc (NASDAQ: AXSM), the best-performing biotech of the year, were ripping higher Monday following a positive clinical rea 0 read more.....»»
BeiGene announces data from two clinical trials of Brukinsa at ASH meeting
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FSD Pharma Reports Third Quarter 2019 Financial Results
- Announces intent to initiate Phase 1 first-in-human safety and tolerability trials for its lead candidate, PP 101 micro-PEA during 1Q20 – -Â.....»»
Karuna Therapeutics Shares Rip Higher After Schizophrenia Drug Aces Midstage Trial
Shares of the thinly traded, small-cap biotech Karuna Therapeutics Inc (NASDAQ: KRTX) were moving higher Monday on a positive clinical trial readout. 0 read more.....»»